| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 07/12/2001 | WO2001049688A1 Purine derivatives, process for their preparation and use thereof |
| 07/12/2001 | WO2001049685A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 07/12/2001 | WO2001049684A1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 07/12/2001 | WO2001049676A1 Substituted piperidines, medicaments containing these compounds, and methods for the production thereof |
| 07/12/2001 | WO2001049675A1 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2-mediated disorders |
| 07/12/2001 | WO2001049673A2 Compounds and methods for modulation of estrogen receptors |
| 07/12/2001 | WO2001049670A1 5,10-dihydroacridines as calcium channel blockers |
| 07/12/2001 | WO2001049662A2 Carbazole derivatives as inhibitors of spla2 |
| 07/12/2001 | WO2001049661A1 5-THIA-φ-(SUBSTITUTED PHENYL)-PROSTAGLANDIN E ALCOHOLS, PROCESS FOR PREPARING THE ALCOHOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AS THE ACTIVE INGREDIENT |
| 07/12/2001 | WO2001049657A1 2-`3-amino-4-(n-hydroxyamino)-succinylamino-acetamides for use as cd23 formation inhibitors |
| 07/12/2001 | WO2001049654A2 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 07/12/2001 | WO2001049651A2 Aminomethyl-phenyl-cyclohexanone derivatives |
| 07/12/2001 | WO2001049323A1 Combination therapy for the treatment of inflammatory and respiratory diseases |
| 07/12/2001 | WO2001049321A1 Tnf inhibitors for the treatment of neurological, retinal and muscular disorders |
| 07/12/2001 | WO2001049315A1 Combination therapy for the treatment of inflammatory and respiratory diseases |
| 07/12/2001 | WO2001049312A2 O-superfamily conotoxin peptides |
| 07/12/2001 | WO2001049305A2 Process for obtaining thylakoids from plants, pure thylakoids and use thereof |
| 07/12/2001 | WO2001049303A1 Multivalent electron active compositions and methods of making and using same |
| 07/12/2001 | WO2001049302A1 Compositions and methods for facilitating skin growth and managing skin conditions |
| 07/12/2001 | WO2001049301A1 Methods of using electron active compounds for managing cancer |
| 07/12/2001 | WO2001049288A1 Novel compounds and compositions as protease inhibitors |
| 07/12/2001 | WO2001049287A1 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy |
| 07/12/2001 | WO2001049275A2 Methods and compositions for mitigating pain using nitrate esters |
| 07/12/2001 | WO2001049163A1 Pp14 fusion proteins and methods for making and using the same |
| 07/12/2001 | WO2001044207A8 Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them |
| 07/12/2001 | WO2001027096A9 Aminomethyl-(hetero)aryl derivatives and their use as tryptase inhibitors |
| 07/12/2001 | WO2001008677A8 Methods of inhibiting osteoclast activity |
| 07/12/2001 | WO2000078697A3 High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof |
| 07/12/2001 | WO2000074724A3 Conjugates comprising cytokines and nucleic acids for treating proliferating cells |
| 07/12/2001 | WO2000034447A8 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 07/12/2001 | WO2000000510A3 Growth factor modulators |
| 07/12/2001 | US20010007873 Compounds such as 4-(6-amino-pyridin-2-yl)-3-methoxyphenol as nitric oxide synthase inhibitors used to treat central nervous system disorders, inflammatory disorders, septic shock, etc... |
| 07/12/2001 | US20010007693 Food products having enhanced cocoa polyphenol content and processes for producing the same |
| 07/12/2001 | DE19963868A1 Neue substituierte Piperidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung New substituted piperidines, pharmaceutical compositions containing them and methods for their preparation |
| 07/12/2001 | DE19963859A1 Bi- oder Oligomer eines Di-, Tri-, Quattro- oder Pentamers von rekombinanten Fusionsproteinen Bi- or oligomer of a di-, tri-, Quattro or pentamer of recombinant fusion proteins |
| 07/12/2001 | DE19963179A1 Substituierte 1- und 2-Naphthol-Mannichbasen Substituted 1- and 2-naphthol Mannich bases |
| 07/12/2001 | DE19963174A1 Substituierte Pyrrol-Mannichbasen Substituted pyrrole Mannich bases |
| 07/12/2001 | DE10000312A1 Substituierte Aminomethyl-Phenyl-Cyclohexanderivate Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 07/12/2001 | DE10000311A1 Aminomethyl-Phonyl-Cyclohexanonderivate Aminomethyl-Phonyl-cyclohexanone derivatives |
| 07/12/2001 | CA2475413A1 Compositions and methods for treating conditions responsive to estrogen |
| 07/12/2001 | CA2475393A1 Compositions and methods for treating conditions responsive to estrogen |
| 07/12/2001 | CA2396529A1 O-superfamily conotoxin peptides |
| 07/12/2001 | CA2396315A1 Novel substituted pyrazolo[4,3-e]diazepines, pharmaceutical compositions containing them, use as medicinal products and processes for preparing them |
| 07/12/2001 | CA2396310A1 Aminomethyl-phenyl-cyclohexanone derivatives |
| 07/12/2001 | CA2396304A1 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 07/12/2001 | CA2396276A1 Purine derivatives, process for their preparation and use thereof |
| 07/12/2001 | CA2396257A1 Novel compounds and compositions as protease inhibitors |
| 07/12/2001 | CA2396059A1 Compounds and methods for modulation of estrogen receptors |
| 07/12/2001 | CA2395876A1 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | CA2395795A1 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2-mediated disorders |
| 07/12/2001 | CA2395198A1 Pp14 fusion proteins and methods for making and using the same |
| 07/12/2001 | CA2394199A1 5,10-dihydroacridines as calcium channel blockers |
| 07/12/2001 | CA2394184A1 Methods and compositions for mitigating pain using nitrate esters |
| 07/12/2001 | CA2328634A1 Assay method |
| 07/11/2001 | EP1114823A2 Substituted benzylamino nitrogen containing non-aromatic heterocycles |
| 07/11/2001 | EP1114817A1 Substituted benzylamino piperidine compounds |
| 07/11/2001 | EP1114183A1 Polymorphisms in the human beta1 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases |
| 07/11/2001 | EP1114159A1 Methods and compositions relating to egf-repeat-containing polypeptides |
| 07/11/2001 | EP1114158A2 Human cytoskeleton associated proteins |
| 07/11/2001 | EP1114155A2 Human gpcr proteins |
| 07/11/2001 | EP1114146A2 Human serine/threonine protein kinases |
| 07/11/2001 | EP1114061A1 FACTOR VIIa INHIBITORS |
| 07/11/2001 | EP1114053A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 07/11/2001 | EP1114052A1 4-aminopyrrolopyrimidines as kinase inhibitors |
| 07/11/2001 | EP1114051A1 INHIBITORS OF p38 |
| 07/11/2001 | EP1114048A1 Carboline derivatives as cgmp phosphodiesterase inhibitors |
| 07/11/2001 | EP1114046A1 Interleukin-5 inhibiting 6-azauracil derivatives |
| 07/11/2001 | EP1114039A1 INHIBITORS OF p38 |
| 07/11/2001 | EP1114037A1 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 07/11/2001 | EP1114035A1 Quinazoline derivatives and pharmaceutical applications thereof |
| 07/11/2001 | EP1114029A1 Novel compounds |
| 07/11/2001 | EP1114028A1 Aza-bicycles which modulate the inhibition of cell adhesion |
| 07/11/2001 | EP1113809A2 Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor |
| 07/11/2001 | EP1113800A1 Combinations of tetracyclic cyclic gmp-specific phosphodiesterase inhibitors with further therapeutic agents |
| 07/11/2001 | EP1113797A1 Treatment of persistent pain |
| 07/11/2001 | EP0823896B1 Substituted oximes, hydrazones and olefins as neurokinin antagonists |
| 07/11/2001 | EP0771195B1 Method of inhibiting nitric oxide formation |
| 07/11/2001 | EP0659080B1 Method for the treatment of hair loss |
| 07/11/2001 | CN1303384A Pyrrolo [1,2-a] pyrazine sPLA2 inhibitor |
| 07/11/2001 | CN1303379A 2-Aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 07/11/2001 | CN1303372A New heterocyclically substituted amides, their production and their use |
| 07/11/2001 | CN1303368A 1 Alpha-hydroxy-25-ene-vitamin D, analogs and use thereof |
| 07/11/2001 | CN1303367A Nitric oxide synthase inhibitors |
| 07/11/2001 | CN1303365A Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors |
| 07/11/2001 | CN1303364A Aminocyclohexyl ether compounds and uses thereof |
| 07/11/2001 | CN1303295A Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga |
| 07/11/2001 | CN1303290A sPLA Inhibitor ester |
| 07/11/2001 | CN1303289A Adenosine A3 receptor modulators |
| 07/11/2001 | CN1303283A Thienylazolylal coxyethanamines, their preparation and their application as medicaments |
| 07/11/2001 | CN1303276A Drug delivery system comprising tightly compacted solid medicament stock |
| 07/11/2001 | CN1303272A Preparations for application of anti-inflammatory, especially antiseptic agents and/or agents promoting healing of wounds, to upper respiratory tract and/or ear |
| 07/11/2001 | CN1303271A Preparations for application of anti-inflammatory, especially antiseptic agents and/or agents promoting healing of wounds, to lower respiratory tract |
| 07/11/2001 | CN1302639A Tendon-conditioning analgetic |
| 07/11/2001 | CN1068318C 2-Substituted 1,2,5-thiadiazolidin-3-onel, 1-dioxides and compositions and method of use thereof |
| 07/11/2001 | CN1068305C Process for preparing S(-)-2-(4-isobutyl-phenyl) with antimer of purity more than 90% |
| 07/11/2001 | CN1068219C Slow-released analgesic suppository and its preparation process |
| 07/11/2001 | CN1068215C Pasting preparation for eliminating pain |
| 07/11/2001 | CN1068213C External-use medicine for treating hyperosteogeny, and lumbage and leg pain |
| 07/10/2001 | US6258948 An n-acylamino compound; antiinflammatory agents, autoimmune diseases |
| 07/10/2001 | US6258851 Metalloproteinase inhibitors |